Prognostic impact of interval breast cancer detection in women with pT1a N0M0 breast cancer with HER2-positive status: Results from a multicentre population-based cancer registry study

A. Musolino, F. Falcini, A. Sikokis, D. Boggiani, A. Rimanti, B. Pellegrino, E.M. Silini, N. Campanini, E. Barbieri, C. Zamagni, R. Degli Esposti, L. Cortesi, G. Bisagni, L. Cavanna, A. Frassoldati, P. Sgargi, M. Michiara

Research output: Contribution to journalArticle

Cite this

Musolino, A., Falcini, F., Sikokis, A., Boggiani, D., Rimanti, A., Pellegrino, B., Silini, E. M., Campanini, N., Barbieri, E., Zamagni, C., Degli Esposti, R., Cortesi, L., Bisagni, G., Cavanna, L., Frassoldati, A., Sgargi, P., & Michiara, M. (2018). Prognostic impact of interval breast cancer detection in women with pT1a N0M0 breast cancer with HER2-positive status: Results from a multicentre population-based cancer registry study. European journal of cancer, 88, 10-20. https://doi.org/10.1016/j.ejca.2017.10.024